Connect Biopharma Holdings (CNTB) Key Ratios
$2.04
As on 11-Sep-2026 16:26EDT
Market cap
$116 Mln
Revenue (TTM)
$3 Mln
P/E Ratio
--
P/B Ratio
6.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 1,637.87 | 6,018.75 | 59.69 | -- | -- |
| EBIT | -- | -189.72 | -141.61 | 18.11 | 8.92 |
| Net Profit | -89.10 | -184.38 | -96.63 | 15.23 | 8.95 |
| EPS | -88.58 | -150.98 | -81.00 | 15.37 | 9.04 |
| Book Value | -- | -- | -54.84 | -35.89 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -43,219.43 | -43,219.43 | -1,666.44 | -86,379.69 | -59.17 |
| Net Margin
| -- | -- | -2,816.73 | -- | -- |
| Return on equity
| -48.94 | -72.95 | -256.79 | -82.72 | -16.14 |
| Return on Capital
| -48.69 | -72.77 | -- | -82.18 | -16.09 |
| Return on Assets
| -41.80 | -60.80 | -115.36 | -70.51 | -13.67 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.02 | 0.00 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
--
|
-82.18
|
-16.09
|
-47.79
|
-54.89
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-256.79
Lower than Peers by 216.46
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
-256.79
|
-82.72
|
-16.14
|
-47.96
|
-54.96
|
|
Peer Median
|
-40.33
|
--
|
--
|
--
|
--
|
ROA
-115.36
Lower than Peers by 84.12
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
-115.36
|
-70.51
|
-13.67
|
-41.21
|
-50.78
|
|
Peer Median
|
-31.24
|
--
|
--
|
--
|
--
|
EBIT Margin
-1,666.44
Lower than Peers by 1,583.85
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
-1,666.44
|
-86,379.69
|
-59.17
|
--
|
--
|
|
Peer Median
|
-82.60
|
--
|
--
|
--
|
--
|
Net Margin
-2,816.73
Lower than Peers by 2,725.43
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
-2,816.73
|
-86,687.50
|
-60.03
|
--
|
--
|
|
Peer Median
|
-91.30
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
Lower than Peers by 0.00
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
59.69
Higher than Peers by 5.66
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
59.69
|
-1.00
|
--
|
--
|
--
|
|
Peer Median
|
54.03
|
--
|
--
|
--
|
--
|
EBIT Growth
-141.61
Lower than Peers by 140.59
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
-141.61
|
-258.86
|
75.15
|
47.37
|
41.70
|
|
Peer Median
|
-1.02
|
--
|
--
|
--
|
--
|
Net Profit Growth
-96.63
Lower than Peers by 89.09
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
-96.63
|
-255.00
|
74.84
|
47.41
|
41.62
|
|
Peer Median
|
-7.53
|
--
|
--
|
--
|
--
|
EPS Growth
-81.00
Lower than Peers by 95.23
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
-81.00
|
-2.52
|
0.75
|
0.47
|
0.43
|
|
Peer Median
|
14.23
|
--
|
--
|
--
|
--
|
Book Value Growth
-66.77
Lower than Peers by 56.64
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
-66.77
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.13
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
--
|
0.02
|
0.00
|
0.00
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.01
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
0.01
|
0.01
|
0.00
|
0.00
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.37
Lower than Peers by 3.44
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
2.37
|
3.74
|
11.46
|
4.85
|
9.97
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
2.37
Lower than Peers by 3.33
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
2.37
|
--
|
--
|
5.40
|
10.38
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
--
|
--
|
--
|
-2,695.04
|
-5,599.66
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
93.56
Higher than Peers by 74.55
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
93.56
|
251.56
|
4.04
|
--
|
--
|
|
Peer Median
|
19.01
|
--
|
--
|
--
|
--
|
Asset Turnover
0.04
Lower than Peers by 0.02
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
0.04
|
0.00
|
0.23
|
--
|
--
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
--
|
3,458.46
|
9.84
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
--
|
--
|
-7,720.45
|
-3,765.75
|
-1,139.15
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
--
|
--
|
705.87
|
2,614.79
|
4,371.80
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
--
|
--
|
-8,416.49
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
--
|
-2.83
|
-4.87
|
-1.05
|
-0.40
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
6.49
Higher than Peers by 1.17
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
6.49
|
3.74
|
0.83
|
0.64
|
0.30
|
|
Peer Median
|
5.33
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
0.19
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
0.19
|
-2.08
|
1.18
|
0.86
|
0.89
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
116
Lower than Peers by 26
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Connect Biopharma Holdings (CNTB)
|
116
|
--
|
--
|
--
|
--
|
|
Peer Median
|
142
|
--
|
--
|
--
|
--
|